Basic Information

Gene symbol AFP Synonyms AFPD, FETA, HPAFP Type of gene protein-coding
Gene perturbation-related omics dataset PertOrg
Description alpha fetoprotein

GTO ID GTC3978
Trial ID NCT04612504
Disease Hepatocellular Carcinoma
Altered gene AFP
Therapeutic/Target gene Therapeutic gene
TherapyDNA oncolytic virus
Treatment SynOV1.1
PhasePhase1
Recruitment statusRecruiting
TitleAn Open-label Phase I Study to Evaluate the Safety, Tolerability and Efficacy of SynOV1.1 Recombinant Oncolytic Adenovirus Injection as Monotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Year2022
CountryChina
Company sponsorBeijing Syngentech Co., Ltd.
Other ID(s)Syngentech-SynOV1.1-101
Vector information
Vectoradenovirus
ConstructAd5-AFP-delta24-RGD
Vector typerecombinant replication-competent serotype 5-based adenovirus
Regulatory elementAFP promoter
Viral genome modificationE1B and partial E3 genes was deleted
Vector production methodFor the construction of the corresponding lentiviral vectors, the OVA, fluorescence protein coding sequence, or the annealed shRNA oligonucleotides and miRNA199a were inserted between the restriction sites in the lentiviral transfer plasmids. The lentiviral particles were produced by transient 4-plasmid co-transfection in the HEK293T cell line, concentrated by ultracentrifugation, and then tittered.
Additional featureGM-CSF

Clinical Result

Cohort1: dose level 1
Administration route intratumoral injection
Dosage 3E11 Vp
Age Adult, Older_Adult
References DOI: 10.1158/1538-7445.AM2021-1148
Cohort2: dose level 2
Administration route intratumoral injection
Dosage 1E12 Vp
Age Adult, Older_Adult
References DOI: 10.1158/1538-7445.AM2021-1148
Cohort3: dose level 3
Administration route intratumoral injection
Dosage 3E12 Vp
Age Adult, Older_Adult
References DOI: 10.1158/1538-7445.AM2021-1148

Relationship Graph

Overview of Knowledge Graph